Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proliferating cell nuclear antigen (PCNA) is a highly conserved homotrimeric protein that functions as a DNA sliding clamp and a central scaffold for proteins involved in DNA synthesis and repair (UniProt P12004). While many proteins interact with PCNA via the PIP-box motif, a distinct set of proteins involved in the cellular stress response interact via the APIM (AlkB homolog 2 PCNA-interacting motif) (Gilljam et al., 2009). APIM-dependent protein complexes are crucial for coordinating DNA repair and survival signaling when cells are under genotoxic stress. Targeting these specific interactions, particularly with APIM-mimetic peptides like ATX-101, aims to selectively disrupt the stress-handling capacity of cancer cells. This approach sensitizes tumors to conventional chemotherapy and radiotherapy by preventing the recruitment of repair enzymes to damaged DNA (Slupphaug et al., 2022). Because APIM-mediated interactions are more prominent during stress than during normal replication, this strategy offers a potentially wider therapeutic window compared to broad PCNA inhibitors.
Competitive inhibition of APIM-mediated protein-protein interactions on the PCNA scaffold, which disrupts the recruitment of DNA repair and stress-response proteins, thereby sensitizing cells to genotoxic stress (Müller et al., 2013).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proliferating cell nuclear antigen (PCNA) (PCNA).